Technical Analysis for OVID - Ovid Therapeutics Inc.

Grade Last Price % Change Price Change
grade F 9.18 3.15% 0.28
OVID closed up 3.15 percent on Friday, January 19, 2018, on 1.46 times normal volume.
0 Watchers
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical OVID trend table...

Date Alert Name Type % Chg
Jan 19 Wide Bands Range Expansion 0.00%
Jan 18 Outside Day Range Expansion 3.15%
Jan 18 Wide Bands Range Expansion 3.15%
Jan 17 Inside Day Range Contraction 0.33%
Jan 17 BB Squeeze Ended Range Expansion 0.33%
Jan 17 Wide Bands Range Expansion 0.33%
Jan 16 Expansion Pivot Sell Setup Bearish Swing Setup 5.28%
Jan 16 Bollinger Band Squeeze Range Contraction 5.28%
Jan 16 BB Squeeze + Lower Band Touch Range Contraction 5.28%
Jan 16 Wide Bands Range Expansion 5.28%

Older signals for OVID ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Ovid Therapeutics Inc. (Ovid) is a biopharmaceutical company. The Company is engaged in developing medicines for patients and families living with rare neurological disorders. Its lead drug candidate is OV101. The Company’s second lead drug candidate is OV935. OV101 (gaboxadol) is a delta-selective GABAA receptor agonist. Ovid is developing OV101 for use in both Angelman syndrome and Fragile X syndrome to potentially restore tonic inhibition and relieve several of the symptoms of these disorders. Ovid has initiated the Phase II STARS trial of OV101 in adults with Angelman syndrome and a Phase I trial in adolescents with Angelman syndrome or Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies.
Is OVID a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.93
52 Week Low 5.28
Average Volume 63,744
200-Day Moving Average 0.0
50-Day Moving Average 9.9313
20-Day Moving Average 9.565
10-Day Moving Average 9.239
Average True Range 0.6984
ADX 24.44
+DI 12.05
-DI 25.64
Chandelier Exit (Long, 3 ATRs ) 8.3248
Chandelier Exit (Short, 3 ATRs ) 10.5152
Upper Bollinger Band 10.4085
Lower Bollinger Band 8.7215
Percent B (%b) 0.27
BandWidth 17.637219
MACD Line -0.2511
MACD Signal Line -0.1881
MACD Histogram -0.0631
Fundamentals Value
Market Cap 225.83 Million
Num Shares 24.6 Million
EPS -4.85
Price-to-Earnings (P/E) Ratio -1.89
Price-to-Sales 0.00
Price-to-Book 1.52
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.98
Resistance 3 (R3) 9.92 9.59 9.84
Resistance 2 (R2) 9.59 9.39 9.62 9.80
Resistance 1 (R1) 9.39 9.27 9.49 9.45 9.75
Pivot Point 9.06 9.06 9.12 9.09 9.06
Support 1 (S1) 8.86 8.86 8.96 8.92 8.61
Support 2 (S2) 8.53 8.74 8.56 8.56
Support 3 (S3) 8.33 8.53 8.52
Support 4 (S4) 8.39